These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12492591)
21. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial. Dombret H; Gabert J; Boiron JM; Rigal-Huguet F; Blaise D; Thomas X; Delannoy A; Buzyn A; Bilhou-Nabera C; Cayuela JM; Fenaux P; Bourhis JH; Fegueux N; Charrin C; Boucheix C; Lhéritier V; Espérou H; MacIntyre E; Vernant JP; Fière D; Blood; 2002 Oct; 100(7):2357-66. PubMed ID: 12239143 [TBL] [Abstract][Full Text] [Related]
22. PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia. Mitterbauer G; Födinger M; Scherrer R; Knöbl P; Jäger U; Laczika K; Schwarzinger I; Gaiger A; Geissler K; Greinix H Br J Haematol; 1995 Apr; 89(4):937-41. PubMed ID: 7772540 [TBL] [Abstract][Full Text] [Related]
23. Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Yoon JH; Yhim HY; Kwak JY; Ahn JS; Yang DH; Lee JJ; Kim SJ; Kim JS; Park SJ; Choi CW; Eom HS; Park SK; Choi SY; Kim SH; Kim DW; Lee S Ann Oncol; 2016 Jun; 27(6):1081-1088. PubMed ID: 26951627 [TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia. Stockschläder M; Hegewisch-Becker S; Krüger W; tom Dieck A; Mross K; Hoffknecht M; Berger C; Kohlschütter B; Martin H; Peters S Bone Marrow Transplant; 1995 Nov; 16(5):663-7. PubMed ID: 8547863 [TBL] [Abstract][Full Text] [Related]
25. Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia. Gehly GB; Bryant EM; Lee AM; Kidd PG; Thomas ED Blood; 1991 Jul; 78(2):458-65. PubMed ID: 2070081 [TBL] [Abstract][Full Text] [Related]
26. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT). Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244 [TBL] [Abstract][Full Text] [Related]
27. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study. Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290 [TBL] [Abstract][Full Text] [Related]
28. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia]. Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922 [TBL] [Abstract][Full Text] [Related]
29. Detection of the BCR-ABL gene by reverse transcription/polymerase chain reaction and fluorescence in situ hybridization in a patient with Philadelphia chromosome negative acute lymphoblastic leukaemia. van Rhee F; Kasprzyk A; Jamil A; Dickinson H; Lin F; Cross NC; Galvin MC; Goldman JM; Secker-Walker LM Br J Haematol; 1995 May; 90(1):225-8. PubMed ID: 7786793 [TBL] [Abstract][Full Text] [Related]
31. Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission. Diekmann L; Beelen DW; Quabeck K; Becher R; Schulte Holthausen H; Bützler R; Schaefer UW; Opalka B Acta Haematol; 1994; 92(4):169-75. PubMed ID: 7701913 [TBL] [Abstract][Full Text] [Related]
32. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation. van der Straaten HM; Fijnheer R; Dekker AW; Nieuwenhuis HK; Verdonck LF Br J Haematol; 2001 Jul; 114(1):31-5. PubMed ID: 11472341 [TBL] [Abstract][Full Text] [Related]
33. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia. Mackinnon S; Barnett L; Heller G Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369 [TBL] [Abstract][Full Text] [Related]
34. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse. Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432 [TBL] [Abstract][Full Text] [Related]
35. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia. Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612 [TBL] [Abstract][Full Text] [Related]
36. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Cross NC; Hughes TP; Feng L; O'Shea P; Bungey J; Marks DI; Ferrant A; Martiat P; Goldman JM Br J Haematol; 1993 May; 84(1):67-74. PubMed ID: 8338780 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia. Garg M; Moore H; Tobal K; Liu Yin JA Br J Haematol; 2003 Oct; 123(1):49-59. PubMed ID: 14510942 [TBL] [Abstract][Full Text] [Related]
38. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia. Kohler S; Galili N; Sklar JL; Donlon TA; Blume KG; Cleary ML Leukemia; 1990 Aug; 4(8):541-7. PubMed ID: 2201832 [TBL] [Abstract][Full Text] [Related]
39. Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation. Arnold R; Janssen JW; Heinze B; Bunjes D; Hertenstein B; Wiesneth M; Kubanek B; Heimpel H; Bartram CR Leukemia; 1993 May; 7(5):747-51. PubMed ID: 8483329 [TBL] [Abstract][Full Text] [Related]
40. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT). Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Deliliers GL; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A Br J Haematol; 1996 Dec; 95(4):715-23. PubMed ID: 8982051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]